Abstract

The aim of the work is to scientifically substantiate the basic aspects of developing a methodology for including сost-effectiveness analysis in key processes of clinical trials of medicines. Results. It is established that Ukrainian regulatory system and methodological support of clinical trials with included сost-effectiveness analysis is based on separate regulations in the field of clinical trial and health technology assessment. At the same time, there is no methodological support for the management of сost-effectiveness analysis alongside clinical trials, which would take into account the peculiarities of planning, organizing and conducting such studies. The algorithm of substantiation, development and inclusion of basic components of the analysis of economic effectiveness in the basic processes of planning and the organization of clinical trial of medicines is offered. Emphasis is placed on the need for a proper strategy for analyzing the economic efficiency of the studied medical technologies in clinical trials. The importance of proper selection of economic evaluation models (cost minimization, cost-effectiveness, cost-benefit) in accordance with the purpose of the clinical trial, the primary hypothesis and the selected primary and secondary endpoints is determined. Conclusions. It is determined that there are certain problems of methodological and organizational nature for the development of clinical trials with included сost-effectiveness analysis and economic endpoints. The solution of these tasks should begin at the planning stage of the study by implementing the basic step-by-step recommendations. Innovative treatment technologies that have potential health benefits are often investigated in clinical trials. Thus, the introduction of pharmacoeconomic analysis methods into the structure of traditional clinical trials is an additional important tool to ensure the effective functioning and development of health technology assessment. In further research it is planned to develop scientific and practical approaches to ensure the proper implementation of management processes of сost-effectiveness analysis alongside clinical trial and analysis of data on their results. Keywords: clinical trials; health technology assessment; algorithms; economic models; procedures

Highlights

  • Метою роботи є наукове обґрунтування базових аспектів розробки методики впровадження економічної оцінки медичних технологій у ключові процеси клінічних випробувань лікарських засобів

  • It has been determined that the Ukrainian regulatory system and methodological support of clinical trials with included сost-effectiveness analysis is based on separate regulations in the field of clinical trial and health technology assessment

  • There is no methodological support for the management of the сost-effectiveness analysis in clinical trials, which would take into account the peculiarities of planning, organizing and conducting such studies

Read more

Summary

Results

It has been determined that the Ukrainian regulatory system and methodological support of clinical trials with included сost-effectiveness analysis is based on separate regulations in the field of clinical trial and health technology assessment. There is no methodological support for the management of the сost-effectiveness analysis in clinical trials, which would take into account the peculiarities of planning, organizing and conducting such studies. The algorithm of substantiation, development and inclusion of the main components of the analysis of economic effectiveness in the basic processes of planning and the organization of clinical trial of medicines has been proposed. The attention is focused on the need for a proper strategy for analyzing the economic efficiency of the medical technologies studied in clinical trials. The importance of proper selection of economic evaluation models (cost minimization, cost-effectiveness, cost-benefit) in accordance with the purpose of the clinical trial, the primary hypothesis and the selected primary and secondary endpoints has been determined

Conclusions
Министерства здравоохранения Украины
Управління та економіка в фармації
АНАЛІЗ ОСТАННІХ ДОСЛІДЖЕНЬ І ПУБЛІКАЦІЙ
Нормативна регуляція і методичне забезпечення ОМТ
Складові компоненти залучення аналізу економічної ефективності
Продовження таблиці
ВИСНОВКИ ТА ПЕРСПЕКТИВИ ПОДАЛЬШИХ ДОСЛІДЖЕНЬ
ПЕРЕЛІК ВИКОРИСТАНИХ ДЖЕРЕЛ ІНФОРМАЦІЇ
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call